About Kiran Mazumdar-shaw
Kiran Mazumdar-Shaw, Executive Chairperson of Biocon, has been discussing the company’s growth strategy and the broader challenges facing women entrepreneurs and the Indian biotech sector. In a July 2026 interview with NDTV Profit, she stated that Biocon expects to double its business over the next five fiscals and aims to become a $20 billion company by market capitalization. She attributed this potential growth to the company’s differentiated portfolio of biosimilars, insulins, and GLP-1s, as well as its end-to-end manufacturing capabilities. In a separate conversation at the Future Female Forward event, Mazumdar-Shaw said that 50% of Biocon’s research employees are women. She also commented that women entrepreneurs face greater difficulty than men in raising capital, saying that "banks and financial institutions and venture funds are very reluctant to really invest in women."
Mazumdar-Shaw has also spoken about the need for regulatory reforms in India to foster innovation. At the India Global Forum in London in June 2026, she said that "the world doesn't wait for us" and called for "very rapid regulatory reforms" to help India compete globally. She noted that India is often perceived as a generics-focused country and argued that the country needs to emulate the US ecosystem to retain intellectual property and grow company value. In a BBC StoryWorks documentary on cancer care, she stated that Biocon’s mission is to make life-saving medicines accessible through biosimilars, which she described as having the power to bridge the gap between access and affordability for patients worldwide.
Source: AI-verified profile updated from Kiran Mazumdar-shaw's recent appearances.
Browse all interviews →
Transcript (24 segments)
H
Host0:03
Mark, thank you so much and thank you too to the Minister of course as well. Those conversations are exactly why we do this. This is what this is all about. Please. So please if you would take your seats, we're going to continue those conversations. And as we touched on there, India, the world's fourth largest economy, but by most measures India does remain structurally underweight in a lot of global institutional portfolios. So our next guest has built one of India's most internationally recognized life sciences businesses from the ground up and has managed to navigate that gap. So it is with huge delight that I welcome Kiran Mazumdar Shaw, who's the founder and executive chairperson of Biocon. Please welcome her.
K
Kiran Mazumdar Shaw0:51
Hello.
H
Host0:53
Nice to see you. Delighted to have you here. Can I ask everyone please to take a seat so we can continue our conversation. That would be great. Thank you. We'll just give it one moment while everyone gets sat down. But nice to see you. How are you? You well?
K
Kiran Mazumdar Shaw1:07
Good. Yes. We have to stop meeting like this.
H
Host1:11
Ladies and gents, if you would please take your seats and then we can continue our conversations today. And as I said, joining me here Kiran Mazumdar Shaw, who's the founder and executive chairperson of Biocon. And Kiran, really good to have you here. And there was so much we heard there about the theory and some of the applications of this FTC. I want to talk about the practicalities of what you do because I think in so many ways Biocon is a proof of concept of what Indian innovation can do at global scale. And let's maybe start first of all if we look back and if you sort of look at how institutional investors perceive India today versus how it looked when you were building Biocon. What has changed? Give me a sense of quite how much has changed and maybe what is most stark for you in the perception of India?
K
Kiran Mazumdar Shaw1:59
So, I think you heard from Minister Goyal that India was a very resource-strapped country when I started my company in 1978. And mired in what they used to call red tape and very onerous regulations. I think the government today, over the last 12 years, has absolutely focused on ease of doing business, how do you break down regulatory barriers, how do you free up the economy. And of course, capital inflow and access to capital is much easier than it was when I started the company. I also believe that when I started my company, there was no concept of a startup economy. Today, India has a thriving startup economy. And I think what is very exciting today is really the fact that we have a very dynamic ecosystem, especially in tech startups. India has done something very unique. It created the public digital infrastructure. And I almost kind of compare it to the '90s when internet was a public digital infrastructure. And then of course, the intermediaries leveraged that public digital infrastructure to basically build very large, dominant global organizations like Google, Microsoft, Meta and what have you. Today, I think we are at that same inflection point where I believe that India can do a lot with its own public digital infrastructure. And I think UPI has already demonstrated that. UPI today accounts for 54% of digital transactions in the world. And off that, obviously the absolute financial transactions account for half of that. Because the rest are about other transactions to do with taxation, GST, and what have you, and the direct benefits transactions. But having said that, I think even there we are seeing companies like PhonePe account for 45% of that whole financial transaction segment. AI is also now adding to that. And what I'm looking at in terms of the startup economy is what I like to refer to as combinatorial innovation at scale. I think that's what India is very uniquely positioned to do. How do we innovate at scale, at population scale, that really becomes globally impactful? And that, I think, is the opportunity that both UK and India have in terms of collaboration.
H
Host5:15
And I want to talk about how you did that and maybe the ways that it's different. But first of all, let me ask you this, because we talked there about what's changed. What remains maybe frustratingly the same? What are still the challenges?
K
Kiran Mazumdar Shaw5:28
I think the challenges are that we haven't really focused on removing regulatory barriers fast enough. I think the government is seized of these frustrations that industry is facing. And I think they've actually set up a reforms body to actually look at taking regulations out of the system. Self-regulation, automatic approvals, notifications, e-regulations are definitely going to make a big difference in enabling us to get there, but we have to do it fast. So, I think that's really, to me, one of the biggest roadblocks we have in moving faster.
H
Host6:17
You talked about scaling up and I suppose the message, and we'll come back to it time and time again in these conversations today, is about how we do this structurally and at scale. Talk to me about that scaling up issue because India is such an amazing market in which to do it, but it is not without the challenges of doing so. So, tell me about your journey and maybe how that would be different today if you were doing it again.
K
Kiran Mazumdar Shaw6:41
Yeah, so I think as an entrepreneur, I've always looked at global scale, and global scale requires huge investment. And I think I've had the luxury of decades of investment to get to that global scale. Companies that get into the business today don't have that luxury of time, and so the access to huge capital is difficult. And then to basically crunch that time to scale is also a challenge. So, I think basically, this is something that all companies grapple with today, especially in the sort of physical world. It's easy to scale in the virtual digital world, but it's tough to scale in the physical world. I think that's where I basically have got it right because I made those investments way back. And today, most of those investments are behind us, and I can now start leveraging the objectives of that scale. So, I think it is very important for global impact to be at global scale. And I think access to capital is extremely important to get there. And I think India today is beginning to see a lot of companies address global scale. So, for instance, the PLI scheme that India introduced has seen 25 billion dollars realized in terms of those capex investments. So, I think there are things happening. Even on the research front, India has basically realized and recognized that we are very under-invested in research and innovation. And again, a lot of the research funds have been created to address some of that. But there has to be a virtuous cycle. And I think the UK also has the same problem. Government is doing its bit of starting you off. But you need to follow it with venture capital. Venture capital is simply not flowing at the scale it should. Because again, I go back, UK has the same problems. The regulatory barriers for pre-revenue companies to list on stock exchange or capital markets is very onerous. And it's sometimes not possible. We need to change that. Why is everyone basically migrating their IP to the US? Because the US has that ecosystem. And we need to emulate it. It's not rocket science. I think both India and the UK, if we only emulate the US model, I think we could retain the IP, we can grow the value of these companies, and basically catch up with what the US is doing. But if we don't do that, and if we keep dragging our feet as to well, it's not going to be possible given our very archaic corporate laws, we are going to miss the boat.
H
Host9:42
Do you feel a rarity as a success story? Because I think most people would tend to focus on India for consumer growth, IT, tech. What role do maybe things like life sciences, deep technology play? Are they the next chapter that will really unlock growth rather than that maybe tried and tested method which is tech and consumer growth? That actually life sciences could be somewhere that India really stands out.
K
Kiran Mazumdar Shaw10:11
I think biotech is a huge opportunity because computational biology has never been at this scale before. AI has made a huge transformational difference to the way we look at life sciences. And I think the fact that we've got a lot of capabilities in life sciences, both in terms of talent and in terms of academic innovation, gives you that opportunity to actually leverage it.
H
Host10:39
Do you think the world knows that? Is that message clear?
K
Kiran Mazumdar Shaw10:43
The message is not clear because I think India has always been looked at as a generics country. And therefore India has always been regarded as a reverse engineering kind of life sciences sector. That's changing and I think what we are seeing today is a lot of startups in the biotech sector are being spawned in India but then taking flight to other markets that offer greater venture capital. So I think that's where I'm coming to where even the UK for instance has some of the greatest engineering universities. Imperial College just got ranked number two in the world. You've got Oxford, Cambridge, Glasgow and many other universities who are doing great innovation. But I think you have the same challenge. How do you go beyond the startup phase and scale it? And really create many unicorns. In fact, India has done quite well. India has already created 150 unicorns because of our public digital infrastructure. Where many entrepreneurs have leveraged that base to create at-scale innovation that finds great deployment. But I think we need to really see what more we can do with AI and everything that goes with it.
H
Host12:11
So, if we look at what the FDI unlocks, that's capital. It doesn't change the regulation issue, which we've touched on already.
K
Kiran Mazumdar Shaw12:19
We have to do.
H
Host12:20
Exactly. The infrastructure is increasingly in place. Is this now a marketing issue? Is this what brand India represents on the world stage, that it is about so many other things rather than maybe those tried and tested ones?
K
Kiran Mazumdar Shaw12:33
So, you'll be very interested to know that if you look at talent availability and talent pool, India is actually exporting a lot of talent to cater to global needs. If you look at AI itself, I think there's a lot of export of AI talent to the world. In life sciences, I'm seeing a lot of that export of talent to Europe, to many other parts of the world. So, I'm seeing that the recognition that India has the talent and the capability is there, but I think the recognition that India has innovative companies that are scaling is not there. And that's what I think we need to really focus on. Having said that, we also are seeing some very interesting dynamics play out in India. India is often compared to emerging economies and I personally believe that's really not the right segment that we belong to. Because our fundamentals are materially different. I mean, if you look at what's happening to India today, even at population scale, we are much larger than emerging economies. But what you're also seeing is that our balance sheets are much healthier. Our investment in infrastructure is exponential. Our banks are stronger. And I think we're investing in new areas. You just heard renewable energy, space tech, digital tech companies. And I think it would be great as the ministers referred to, if we could actually create the next Anthropic from this partnership. Because I think that's what is the opportunity. DeepSeek has shown that you don't need deep pockets to really create LLMs. Why can't we develop these very innovative models?
H
Host14:38
There is a frustration, isn't there, and this isn't unique to India, but as all of these things come online, that all of this revolution happens, coming the other way are these huge global headwinds, geopolitics, Trump's tariffs, fractured trade, wars in Europe. What does that change about the equation? So much has made progress and yet at the other way you've got these headwinds that maybe no one saw coming. And that changes the dynamic, doesn't it? Changes where people are willing to invest, the appetite that they may have for investment. And indeed, what they want to invest in because this new world order, and we'll talk about it today, really has arrived. Does it change how you approach business?
K
Kiran Mazumdar Shaw15:23
If you actually look at the numbers, they say a very different story. Everyone's talking about FII sort of moving out of India. It's not true. FII have actually increased their investment in India over the last one year by 14%. I think what has happened is that you've seen a lot of money being taken out of various markets because of the AI frenzy in Silicon Valley. And space tech. SpaceX. I think you're beginning to see that kind of change because you've seen a sellout in recent times of the AI frenzy and the SpaceX kind of over-investment enthusiasm. I'm sure you're going to start seeing a recalibration of investments back into global economies. And India is definitely going to be one of those favored investment destinations. So, I'm not too worried because there's a lot of geopolitics. There's a lot of herd mentalities that we are seeing around the world. But today slowly, I think people are beginning to realize because capital is very tactical. But development is strategic. And India is really investing in development. So, I think you're going to see that shift in perception very soon as India's development agenda is better understood.
H
Host16:52
And maybe a final thought before we finish. If you were creating Biocon now, could you do it in the same way? And would you want to do it in the same way?
K
Kiran Mazumdar Shaw17:02
I could do it much better. Because of all the technologies that are available to me today. And I think I could have done it faster. I've taken 47 years to build Biocon to where it is today. I could have possibly done it in a much shorter time. But it's a different world we're living in today, and when I look back, I think we've done quite well with all the constraints that we have had over the last four or five decades. I think we've got here to a very good place.
H
Host17:37
So good to talk to you. There's so much for us to fit in today, but ladies and gents, Kiran Mazumdar Shaw. Thank you so much.
K
Kiran Mazumdar Shaw17:46
Thanks a lot. Thank you so much.